103D5R is a novel selective inhibitor of hif-1α, markedly decreasing hif-1α protein levels induced by hypoxia or cobaltous ions in a dose- and time-dependent manner References: Belozerov VE, Van Meir EG. Hypoxia inducible factor- a novel target for cancer therapy. Anticancer Drugs. 2005 Oct;16(9):901-9. Review. PubMed PMID: 16162966.

纯度：≥98%

CAS：773852-25-8